Organization
Biolingus
1 clinical trial
Clinical trial
A Phase Ib/IIa, Single Ascending Dose Study of the Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2024-05-01